GKOS Glaukos Corporation Stock Quote

GKOS [NYSE]

Healthcare | Medical Instruments & Supplies | USA

Index	-	P/E	-	EPS (ttm)	-0.61	Insider Own	2.40%	Shs Outstand	47.05M	Perf Week	1.81%
Market Cap	1.87B	Forward P/E	-	EPS next Y	-1.30	Insider Trans	0.00%	Shs Float	45.50M	Perf Month	-24.75%
Income	-27.70M	PEG	-	EPS next Q	-0.44	Inst Own	93.40%	Short Float	3.96%	Perf Quarter	-26.58%
Sales	293.70M	P/S	6.37	EPS this Y	60.50%	Inst Trans	-0.63%	Short Ratio	3.74	Perf Half Y	-14.66%
Book/sh	12.70	P/B	3.14	EPS next Y	25.30%	ROA	-2.60%	Target Price	54.29	Perf Year	-46.65%
Cash/sh	8.85	P/C	4.50	EPS next 5Y	8.00%	ROE	-4.70%	52W Range	33.33 - 87.24	Perf YTD	-10.37%
Dividend	-	P/FCF	-	EPS past 5Y	-60.40%	ROI	-3.50%	52W High	-54.34%	Beta	1.56
Dividend %	-	Quick Ratio	8.40	Sales past 5Y	20.80%	Gross Margin	77.20%	52W Low	19.50%	ATR	2.71
Employees	727	Current Ratio	8.80	Sales Q/Q	-0.40%	Oper. Margin	-3.80%	RSI (14)	39.43	Volatility	4.75% 7.07%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	130.10%	Profit Margin	-9.40%	Rel Volume	0.54	Prev Close	38.94
Shortable	Yes	LT Debt/Eq	0.59	Earnings	May 04 AMC	Payout	-	Avg Volume	481.56K	Price	39.83
Recom	2.50	SMA20	-3.91%	SMA50	-22.57%	SMA200	-20.52%	Volume	262,240	Change	2.29%

Feb-03-22

Upgrade

William Blair

Mkt Perform → Outperform

Jan-19-22

Upgrade

Wells Fargo

Underweight → Equal Weight

$56

Jan-18-22

Upgrade

BTIG Research

Neutral → Buy

$61

Nov-03-21

Upgrade

Stephens

Equal-Weight → Overweight

$68

Jul-26-21

Downgrade

Stephens

Overweight → Equal-Weight

$70

Jul-20-21

Downgrade

Wells Fargo

Equal Weight → Underweight

$41

Jul-14-21

Downgrade

William Blair

Outperform → Mkt Perform

Jul-14-21

Downgrade

Oppenheimer

Outperform → Perform

Apr-08-21

Upgrade

Oppenheimer

Perform → Outperform

$100

Jan-29-21

Downgrade

Piper Sandler

Overweight → Neutral

$70 → $80

Dec-16-20

Upgrade

Citigroup

Sell → Neutral

$50 → $72

Dec-09-20

Initiated

Oppenheimer

Perform

Nov-17-20

Upgrade

Wells Fargo

Underweight → Equal Weight

$68

Oct-08-20

Downgrade

JP Morgan

Neutral → Underweight

$50

Jun-15-20

Initiated

Jefferies

Hold

$44

Mar-05-20

Initiated

Citigroup

Sell

$40

Feb-28-20

Downgrade

JP Morgan

Overweight → Neutral

$55

Jan-06-20

Upgrade

Berenberg

Hold → Buy

$60 → $65

Dec-12-19

Downgrade

Wells Fargo

Outperform → Underperform

Sep-30-19

Downgrade

BofA/Merrill

Buy → Underperform

May-20-22 07:00AM	Glaukos Announces Participation in the Piper Sandler Virtual Ophthalmology Symposium Business Wire
May-10-22 11:04AM	Glaukos (GKOS) Stock Falls 25.9% Despite Q1 Earnings Beat Zacks
May-04-22 06:45PM	Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:05PM	Glaukos Corporation Announces First Quarter 2022 Financial Results Business Wire
May-03-22 11:13AM	Glaukos (NYSE:GKOS) Has Debt But No Earnings; Should You Worry? Simply Wall St.
Apr-21-22 07:00AM	Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting Business Wire
Apr-20-22 07:00AM	Glaukos Announces the Release of its 2021 Sustainability Report Business Wire
Apr-13-22 07:00AM	Glaukos to Release First Quarter 2022 Financial Results after Market Close on May 4 Business Wire
Mar-30-22 11:33AM	Here's Why You Should Hold on to Glaukos (GKOS) Stock Now Zacks
Mar-14-22 07:00AM	Glaukos Announces Commencement of Phase 2 Corneal Health Clinical Program for Third-Generation iLink Therapy Business Wire
Feb-24-22 04:41AM	Glaukos Corporation (NYSE:GKOS) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock? Simply Wall St. +6.46%
Feb-23-22 11:07AM	Glaukos (GKOS) Q4 Earnings and Revenues Surpass Estimates Zacks
Feb-22-22 06:15PM	Glaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates Zacks
04:05PM	Glaukos Corporation Announces Fourth Quarter and Full Year 2021 Financial Results Business Wire
Feb-15-22 03:01PM	Earnings Preview: Glaukos (GKOS) Q4 Earnings Expected to Decline Zacks
Feb-07-22 04:15PM	Glaukos Announces Executive Leadership Changes Business Wire
Feb-01-22 07:00AM	Glaukos Corporation to Release Fourth Quarter and Full Year 2021 Financial Results after Market Close on February 22 Business Wire
Jan-12-22 05:47AM	Glaukos' iDose TR Shows Sustained Reduction In Ocular Pressure, Favorable Safety Profile Benzinga -5.17%
Jan-11-22 04:10PM	Glaukos iDose® TR Demonstrates Sustained IOP Reduction and Favorable Safety Profile Over 36 Months in Phase 2b Study Business Wire +10.78%
04:10PM	Glaukos Announces First Patient Enrolled in Phase 2 Clinical Trial for Presbyopia Business Wire
04:10PM	Glaukos Announces First Patient Enrolled in Phase 2 Clinical Trial for Dry Eye Disease Business Wire
Jan-10-22 05:43AM	Investors in Glaukos (NYSE:GKOS) from a year ago are still down 39%, even after 7.0% gain this past week Simply Wall St.
Jan-06-22 04:10PM	Glaukos Announces FDA 510(k) Clearance of iPRIME Business Wire
Dec-29-21 11:27AM	Here's Why You Should Hold on to Glaukos (GKOS) Stock Now Zacks
07:00AM	Glaukos Announces Participation in the J.P. Morgan Healthcare Conference Business Wire
Dec-20-21 04:15PM	Glaukos Announces Retirement of William J. Link, Ph.D., as Chairman of the Board and Election of Thomas W. Burns as New Chairman and Mark J. Foley as Lead Independent Director Business Wire
Dec-17-21 08:38PM	Baillie Gifford Positive Change Equities Fund Buys Orsted A/S, Deere, Coursera Inc, Sells ... GuruFocus.com
05:46PM	Hedge Funds Are Piling Into Glaukos Corporation (GKOS) Insider Monkey
Dec-11-21 05:38AM	Penn Series Mid Cap Growth Fund Buys Heico Corp, Levi Strauss, Pinnacle Financial Partners Inc, ... GuruFocus.com
Dec-09-21 05:38PM	Azzad Funds Buys Heico Corp, CoStar Group Inc, Zimmer Biomet Holdings Inc, Sells Zendesk Inc, ... GuruFocus.com
Dec-07-21 08:50AM	Heres Why Artisan Partners Sold its Glaukos Corp. (GKOS) Stake Insider Monkey
Nov-30-21 10:15AM	Here's Why You Should Hold on to Glaukos (GKOS) Stock Now Zacks
04:00AM	Glaukos Corp (GKOS) FY 2021 Earnings Call Transcript Motley Fool
Nov-11-21 07:00AM	Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 American Academy of Ophthalmology Annual Meeting Business Wire
Nov-08-21 10:16AM	Glaukos (GKOS) Gains 3.6% Despite Reporting a Loss in Q3 Zacks -5.69%
Nov-07-21 09:30AM	Glaukos Corp (GKOS) Q3 2021 Earnings Call Transcript Motley Fool
Nov-04-21 06:45PM	Glaukos (GKOS) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:10PM	Glaukos Corporation Announces Third Quarter 2021 Financial Results Business Wire
Nov-03-21 12:39PM	Why Glaukos Stock Is Soaring Today Motley Fool +18.64%
11:54AM	Why Are Glaukos Shares Rallying Today? Benzinga
07:30AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday InvestorPlace
07:03AM	25 Stocks Moving in Wednesday's Pre-Market Session Benzinga
05:59AM	Glaukos Stock Jumps After Upgrade on Medicare Reimbursement Rules Investing.com
Oct-29-21 11:38AM	Hedge Funds Are Warming Up To Glaukos Corporation (GKOS) Insider Monkey
Oct-28-21 03:06PM	Analysts Estimate Glaukos (GKOS) to Report a Decline in Earnings: What to Look Out for Zacks +6.94%
Oct-14-21 07:00AM	Glaukos Corporation to Release Third Quarter 2021 Financial Results after Market Close on November 4 Business Wire
Oct-11-21 08:12AM	Is Glaukos (NYSE:GKOS) Using Too Much Debt? Simply Wall St.
Oct-07-21 04:15PM	Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 European Society of Cataract and Refractive Surgeons Annual Meeting Business Wire
Sep-20-21 10:19AM	Here's Why You Should Hold on to Glaukos (GKOS) Stock Now Zacks
07:00AM	Glaukos Announces Licensing Agreement with Attillaps Holdings, Inc. Business Wire
Sep-15-21 09:19AM	Ivantis To Pay $60M In Patent Litigation Settlement With Glaukos Benzinga
07:00AM	Glaukos Announces Settlement of Patent Litigation with Ivantis, Inc. Business Wire
Sep-09-21 09:24AM	Glaukos (GKOS) Announces PMA Submission, Boosts iStent Platform Zacks
Sep-06-21 01:29PM	Heres Why Artisan Partners Sold its Glaukos Corporation (GKOS) Position Insider Monkey
Sep-03-21 07:00AM	Glaukos Announces Submission of Supplemental Pre-Market Approval Application for iStent infinite Business Wire
Aug-26-21 07:00AM	Glaukos Announces Participation in the Wells Fargo Healthcare Conference Business Wire
Aug-23-21 07:00AM	Glaukos Announces Market-Leading Clinical Milestone of 200 Peer-Reviewed Publications on iStent® Technologies Business Wire
Aug-17-21 10:49AM	Here's Why You Should Retain Glaukos (GKOS) Stock Right Now Zacks
Aug-09-21 09:01AM	Glaukos (GKOS) Stock Gains 0.1% Following Lower Loss in Q2 Zacks +6.51%
Aug-06-21 02:30PM	Glaukos Corp (GKOS) Q2 2021 Earnings Call Transcript Motley Fool
Aug-05-21 05:55PM	Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:10PM	Glaukos Corporation Announces Second Quarter 2021 Financial Results Business Wire
Jul-29-21 03:05PM	Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jul-27-21 10:27PM	Glaukos Corporation (GKOS): Are Hedge Funds Right About This Stock? Insider Monkey
Jul-22-21 07:00AM	Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 American Society of Cataract and Refractive Surgery Annual Meeting Business Wire
Jul-20-21 03:45PM	Why Glaukos Stock Sank Today Motley Fool -14.88%
Jul-16-21 06:14AM	Glaukos (GKOS) is Oversold: Can It Recover? Zacks
Jul-15-21 04:15PM	Glaukos Corporation to Release Second Quarter 2021 Financial Results after Market Close on August 5 Business Wire
Jul-14-21 11:14AM	Why Glaukos Stock Is Tanking Today Motley Fool -21.41%
07:43AM	William Blair Downgrades Glaukos After Disappointing CMS Rate; Shares Drop Benzinga
02:00AM	Glaukos Comments on the Centers for Medicare and Medicaid Services 2022 Proposed Physician Fee Schedule Business Wire
Jul-11-21 05:58AM	Are Investors Undervaluing Glaukos Corporation (NYSE:GKOS) By 33%? Simply Wall St.
Jul-02-21 08:27AM	Here's Why You Should Retain Glaukos (GKOS) Stock Right Now Zacks
Jul-01-21 07:22PM	Glaukos Stock Sees Its Relative Strength Rating Improve To Key Above-80 Level Investor's Business Daily
Jun-10-21 07:00AM	Glaukos Achieves Pipeline Milestone with Completion of Patient Enrollment in U.S. NDA Phase 3 Clinical Trials for iDose® TR Business Wire
Jun-08-21 07:00AM	Glaukos Announces Australias TGA Regulatory Approval for PRESERFLO MicroShunt Business Wire
Jun-04-21 11:31AM	Glaukos (GKOS) Down 11.1% Since Last Earnings Report: Can It Rebound? Zacks
May-27-21 07:48AM	Here's Why We Think Glaukos Corporation's (NYSE:GKOS) CEO Compensation Looks Fair for the time being Simply Wall St.
May-25-21 10:21AM	Here's Why You Should Retain Glaukos (GKOS) Stock for Now Zacks
May-19-21 09:58AM	Glaukos Inks New Agreement With Santen; Street Sees 23.8% Upside SmarterAnalyst
07:00AM	Glaukos Announces Participation in the William Blair 41st Annual Growth Stock Conference Business Wire
May-18-21 06:00PM	Glaukos Expands its PRESERFLO MicroShunt Relationship with Santen via New License Agreement Business Wire
12:28PM	Artisan Partners: We Believe Glaukos Corp. (GKOS) has Significant Profit-Cycle Potential Insider Monkey
May-12-21 09:43AM	Glaukos (GKOS) Loses 14.3% Despite Narrower Loss in Q1 Zacks
May-09-21 05:19AM	Announcing: Glaukos (NYSE:GKOS) Stock Increased An Energizing 243% In The Last Five Years Simply Wall St.
May-05-21 08:01PM	Glaukos Corp (GKOS) Q1 2021 Earnings Call Transcript Motley Fool
06:35PM	Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:10PM	Glaukos Corporation Announces First Quarter 2021 Financial Results Business Wire
02:45PM	Glaukos Corp. to Host Earnings Call ACCESSWIRE
Apr-28-21 12:33PM	Glaukos (GKOS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release Zacks
Apr-27-21 07:00AM	Glaukos Announces the Release of its 2020 Sustainability Report Business Wire
Apr-22-21 07:00AM	Glaukos Announces Global Licensing Agreement Amendment with Intratus, Inc. to Include the Treatment of Presbyopia Business Wire
Apr-14-21 04:15PM	Glaukos Corporation to Release First Quarter 2021 Financial Results after Market Close on May 5 Business Wire
Mar-27-21 11:31AM	Why Is Glaukos (GKOS) Down 7.1% Since Last Earnings Report? Zacks
Mar-24-21 03:23AM	When Should You Buy Glaukos Corporation (NYSE:GKOS)? Simply Wall St.
Mar-23-21 09:14AM	Here's Why You Should Retain Glaukos (GKOS) Stock Right Now Zacks
Mar-08-21 07:00AM	Glaukos to Support World Glaucoma Week with Patient Education Campaign and Free Screening Initiatives Business Wire
Mar-02-21 07:00AM	Glaukos Announces Participation in Oppenheimer Healthcare Conference Business Wire
Mar-01-21 04:10PM	Glaukos Appoints Denice Torres and Dr. Leana Wen to its Board of Directors Business Wire
Feb-26-21 11:31AM	Glaukos Corp (GKOS) Q4 2020 Earnings Call Transcript Motley Fool

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Burns Thomas William	Chief Executive Officer	Aug 06	Option Exercise	4.44	286,880	1,273,068	635,062	Aug 09 08:26 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience